Search This Blog

Thursday, January 26, 2023

CytomX Hits Milestone in Collaboration with Astellas

 Achievement of clinical candidate is the first in the multi-target collaboration and triggers a $5 million milestone payment to CytomX-

-CytomX-retained US co-commercialization and economic rights for select programs-

https://finance.yahoo.com/news/cytomx-therapeutics-announces-milestone-achievement-120000436.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.